Glaucoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Glaucoma Clinical Trial Report Overview
A total of 1,696 glaucoma clinical trials were conducted as of January 2024. The glaucoma clinical trial report provides a comprehensive understanding of the glaucoma clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · South and Central America |
Key Countries | · The US
· China · Japan · India · Australia |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Alcon Inc
· AbbVie Inc · Santen Pharmaceutical Co Ltd · Pfizer Inc · Viatris Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Glaucoma Clinical Trials Segmentation by Regions and Countries
Asia-Pacific led the glaucoma clinical trials landscape with more than 30% of the clinical trials conducted as of January 2024.
The key regions considered for Glaucoma clinical trials analysis are Asia-Pacific, Europe, North America, Middle East and Africa, and South and Central America.
In the country-wise analysis, the US had the highest number of glaucoma clinical trials, as of January 2024. Germany had the highest average patient enrollment of glaucoma clinical trials, during the same time.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Japan had the highest proportion of Glaucoma to Ophthalmology clinical trials as of January 2024.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Brazil had the highest proportion of Glaucoma to Ophthalmology clinical trials as of January 2024.
Glaucoma Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Glaucoma Clinical Trials
Download a Free Sample Report
Glaucoma Clinical Trials Segmentation by Sponsor Types
The key sponsor types for glaucoma clinical trials are company, institution, and the government. As of January 2024, more than 50% of glaucoma clinical trials conducted were sponsored by company sponsor type, followed by the institution.
Glaucoma Clinical Trials Analysis by Sponsor Type, 2023 (%)
Buy the Full Report for More Insights into the Glaucoma Clinical Trials Sponsor Types
Glaucoma Clinical Trials - Competitive Landscape
In 2023, Alcon Inc conducted the highest number of Glaucoma clinical trials
A few of the leading sponsors for glaucoma clinical trials are:
- Alcon Inc
- AbbVie Inc
- Santen Pharmaceutical Co Ltd
- Pfizer Inc
- Viatris Inc
Glaucoma Clinical Trials Analysis by Leading Companies, 2023 (%)
Buy the Full Report to Know More About the Leading Players of Glaucoma Clinical Trials
Segments Covered in the Report
Glaucoma Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Glaucoma Clinical Trials Country Outlook (2023)
- The US
- China
- Japan
- India
- Australia
Glaucoma Clinical Trials Sponsor Type Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Formulate key investment strategies.
- Identify time-saving and cost-efficient locations to conduct clinical trials.
- Get top-level analysis of the global clinical trials market to help in identifying key business opportunities.
- Understand trial count and enrollment trends by country in the global therapeutics market.
- Interpret the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Understand clinical trial assessment of the indication on a global, regional, and country level.
AbbVie Inc
Santen Pharmaceutical Co Ltd
Pfizer Inc
Viatris Inc
Merck & Co Inc
Novartis AG
Kowa Co Ltd
Bausch Health Companies Inc
Senju Pharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of glaucoma clinical trials in January 2024?
Asia-Pacific accounted for the highest number of glaucoma clinical trials as of January 2024.
-
Which country conducted the highest number of glaucoma clinical trials in January 2024?
The US conducted the highest number of glaucoma clinical trials as of January 2024.
-
Which sponsor type was the most prominent in the glaucoma clinical trials in January 2024?
As of January 2024, most of the glaucoma clinical trials conducted were sponsored by company sponsor type.
-
Which are the leading sponsors of glaucoma clinical trials?
A few of the leading sponsors of glaucoma clinical trials are Alcon Inc, AbbVie Inc, Santen Pharmaceutical Co Ltd, Pfizer Inc, and Viatris Inc, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.